UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047799
Receipt number R000054490
Scientific Title The 2nd Matsue City Pancreatic Cancer Project
Date of disclosure of the study information 2022/05/25
Last modified on 2022/05/19 05:50:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The 2nd Matsue City Pancreatic Cancer Project

Acronym

The 2nd Matsue City Pancreatic Cancer Project

Scientific Title

The 2nd Matsue City Pancreatic Cancer Project

Scientific Title:Acronym

The 2nd Matsue City Pancreatic Cancer Project

Region

Japan


Condition

Condition

Pancreatic tumor

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We verify the frequency of pancreatic cancer detection through collaboration between practitioners and general hospital doctors.

Basic objectives2

Others

Basic objectives -Others

a prospective observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Blood tests, abdominal ultrasonography, MRI, computed tomography, endoscopic ultrasonography will be performed on symptomatic patients to confirm the frequency of pancreatic cancer detection.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

Patients suspected of having pancreatic cancer due to clinical symptoms

Patients with multiple risk factors for pancreatic cancer

Patients whose clinical course cannot deny pancreatic cancer

Key exclusion criteria

none

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Kazuya
Middle name
Last name Matsumoto

Organization

Medical corporation Irisawa Medical Clinic

Division name

Internal Medicine

Zip code

690-0025

Address

285-6, Yawata-cho, Matsue 690-0025

TEL

0852-38-8211

Email

matsumotokazuya@tottori-u.ac.jp


Public contact

Name of contact person

1st name Kazuya
Middle name
Last name Matsumoto

Organization

Medical corporation Irisawa Medical Clinic

Division name

Internal Medicine

Zip code

690-0025

Address

285-6, Yawata-cho, Matsue 690-0025

TEL

0852-38-8211

Homepage URL


Email

matsumotokazuya@tottori-u.ac.jp


Sponsor or person

Institute

Matsue Medical Association

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Matsue Red Cross Hospital

Address

200, Horo-cho, Matsue, 690-0086

Tel

0852-24-2111

Email

kushiyama_yoshinori@matsue.jrc.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 05 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 01 Month 06 Day

Date of IRB

2022 Year 03 Month 31 Day

Anticipated trial start date

2022 Year 06 Month 01 Day

Last follow-up date

2027 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

If abdominal ultrasonography reveals dilated main pancreatic duct, pancreatic cyst, or pancreatic tumor lesion, blood test reveals abnormalities, or if pancreatic cancer cannot be ruled out from the clinical course, refer to a detailed examination medical institution. Cases that have undergone a further examination will be registered in the "2nd Matsue City Pancreatic Cancer Project".


Management information

Registered date

2022 Year 05 Month 19 Day

Last modified on

2022 Year 05 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054490


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name